Posted by Michael Wonder on 25 Sep 2023
ICER releases draft evidence report on treatment for pulmonary arterial hypertension
25 September 2023 - Registration now open for 5 October “Early Insights” webinar.
The ICER today released a draft evidence report assessing the comparative clinical effectiveness and value of sotatercept (Merck) for pulmonary arterial hypertension.
